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Summary 
The surface of streptococci presents an array of different proteins, each designed to perform a 
specific function. In an attempt to understand the early events in group A streptococci infection, 
we have identified and purified a major surface protein from group A type 6 streptococci that 
has both an enzymatic activity and a binding capacity for a variety of proteins. Mass spectrometric 
analysis of the purified molecule revealed a monomer of 35.8 kD. Molecular sieve chromatography 
and sodium dodecyl sulfate (SDS)-gel dectrophoresis suggest that the native conformation of 
the protein is likely to be a tetramer of 156 kD. NH2-terminal amino acid sequence analysis 
revealed 83%  homology in the first  18 residues  and about 56%  in the first 39 residues  with 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)  of eukaryotic or bacterial  origin. This 
streptococcal surface  GAPDH  (SDH)  exhibits  a  dose-dependent dehydrogenase activity on 
glyceraldehyde-3-phosphate in the presence of fl-nicotinamide adenine dinucleotide both in its 
pure form and on the streptococcal surface. Its sensitivity to trypsin on whole organism and 
its inability to be removed with 2 M NaCI or 2% SDS support its surface location and tight 
attachment to the streptococcal cell. Affinity-purified antibodies to SDH detected the presence 
of this protein on the surface of all M serotypes of group A streptococcal tested. Purified SDH 
was found to bind to fibronectin, lysozyme, as well as the cytoskeletal proteins myosin and actin. 
The binding activity to myosin was found to be localized  to the globular heavy meromyosin 
domain. SDH did not bind to streptococcal M protein, tropomyosin, or the coiled-coil domain 
of myosin. The multiple binding capacity of the SDH in conjunction with its GAPDH activity 
may play a role in the colonization, internalization, and the subsequent proliferation of group 
A  streptococci. 
T 
he initial events governing the colonization of the pha- 
ryngeal mucosa by group A streptococci are not under- 
stood. To date at least six structurally similar proteins have 
been identified on the surface of these organisms (1). The 
similarity among these different molecules is based on the 
presence of repeat regions in their  surface-exposed  NH2- 
terminal half and a highly conserved COOH-terminal por- 
tion buried within the cell and responsible for attachment 
(2). Although the repeat segments of some of these mole- 
cules have been shown to perform a particular biological func- 
tion (1), their role in colonization and infection has not been 
fully explored. Earlier studies have implicated both the sur- 
face M protein (3) and lipoteichoic acid (LTA)  1 (4) in the ad- 
1 Abbreviations used in  this paper: DTT,  dithiothreitol;  G-3-P, glycer- 
aldehyde-3-phosphate;  GAPDH, gly~aldehyde-3-phosphate  dehydrogenase; 
HMM, heavy meromyosin; k, kinetic; LMM, light meromyosin; LTA, 
lipotechoic  acid; NAD,  /3-nicotinamide adenine dinudeotide;  SDH, 
streptococcal surface dehydrogenase. 
herence of group A streptococci to epithelial cells, however, 
more recent data have indicated that neither the M protein 
nor LTA (5, 6) are directly involved in the colonization process. 
In the present communication we purify and characterize 
a major surface molecule from group A streptococci (termed 
streptococcal surface dehydrogenase [SDH]) that is distinct 
from M protein (7), and have determined its NH2-terminal 
amino acid sequence as a first step in understanding the mol- 
ecules involved in mucosal colonization. Sequence and enzy- 
matic results reveal that this surface protein is in fact a glyco- 
lyric enzyme with glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH)  activity.  In eukaryotes,  glycolytic enzymes, of 
which GAPDH is a key one, are found to be associated with 
membranes and subcellular  cytoskeletal  structures (8). Re- 
cently, proteins with a similar enzymatic activity have been 
shown to be membrane bound (9-12) and involved in a va- 
riety of functions independent from its catalytic property (9, 
13-16).  In the case of SDH, we have found that it is able 
to bind to fibronectin, lysozyme, and cytoskeletal proteins. 
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as important constituents of human saliva (17, 18). The sur- 
faces of both Gram-negative and Gram-positive bacteria have 
been shown to contain molecules that bind to fibronectin 
and lysozyme (19-21).  While a fibronectin binding protein 
in Staphylococcus aureus has been identified (22), characterized 
(23), cloned, and sequenced (24, 25),  and implicated in the 
adherence of these organisms, the presence of a similar mole- 
cule on group A streptococci is suggested (5) with a prob- 
able role in initial adherence events. Talay et al. (6) have re- 
cently provided evidence that fibronectin binding molecules 
found on the streptococcal surface represent a strain-dependent 
complex of proteins with variable molecular masses distinct 
from the M protein; however, none have been characterized. 
It is clear  that the ability to bind to the fibronectin on 
the surface of mammalian cells may be an important first step 
in the colonization of mucosal surfaces by microorganisms 
(5, 26).  However, the soluble form of fibronectin found in 
saliva (17, 27) may also play a key role in the colonization 
process,  since this form would be the first encountered by 
the incoming bacterium and may serve as a competitive in- 
hibitor. Similarly, lysozyme, an important secretory compo- 
nent of the host's defence against infection by Gram-positive 
bacteria, is ineffective in the destruction of group A strep- 
tococci (28; our personal observation). While saliva (29) and 
its component lysozyme have been shown to be involved in 
the aggregation of microorganisms (19), including group A 
streptococci, in the process of microbial clearance from the 
oral mucosa, its association with molecules responsible for 
fibronectin binding has not been described.  In our studies, 
designed to dissect the interactions between the streptococcus 
and the pharyngeal mucosa, we reasoned that molecules found 
in human saliva may combine with streptococcal surface mol- 
ecules and thus influence the colonization process. 
In  view  of  the  potential  muhifunctional property  of 
GAPDH-like molecules, the SDH protein found on the strep- 
tococcal surface may play a role in the infection process. The 
present study details the enzymatic and binding characteris- 
tics  of this major surface molecule. 
Materials and Methods 
Materials.  Human fibronectin and glutaradialdehyde-activated 
affinity  beads were obtained from Boehringer Mannheim Biochem- 
icals (Indianapolis, IN). Prestained molecule mass standards were 
purchased from Bethesda Research Laboratories (Gaithersburg, 
MD). Polyvinyledine  difluoride  (PVDF) membrane  "Immobilon-P" 
was from Millipore Corp. (Bedford, MA). NalZSI  was from New 
England Nuclear (Boston, MA). All other chemicals and reagents, 
unless otherwise indicated, were purchased from Sigma Chemical 
Co. (St. Louis, MO). 
Bacteria.  Group A B-hemolytic  streptococcal strains of various 
M types and standard strains used for streptococcal grouping were 
from The Rockefeller University culture collection (New York, 
NY) and are listed as follows: M2(D626), M4(D896), M5(Man- 
frando), M6(D471), M24(CS24), M29(D23), M41(C101/103/4), 
M57(A995), M58(D774), M60(D398), M-(T28/51/4)  (30); group 
A, J17A4 (an M-  strain); group A variant, A486var; group B, 
090R; group C, C74; group D, D76; group E, K131; group F, 
F68C; group G, D166B; group H, Fg0A; group L, D167B; and 
group N, C559. 
Lysin Extraction and Location of the 39-kD Protein.  A crude ex- 
tract containing the major streptococcal surface  proteins was pre- 
pared using the procedure of lysin extraction to remove the strep- 
tococcal cell wall, as described  before (31, 32). M6 strain D471 was 
grown to a stationary phase of culture at 37~  for 18 h in 4-6-liter 
batches of Todd-Hewitt broth. Bacteria were peUeted by centrifu- 
gation and washed in 50 mM sodium acetate buffer, pH 5.5, and 
suspended in the same buffer containing 30% raffinose  and 5 mM 
~.  Lysin  was added to the suspension  (1:100 dilution; 120 U/ml) 
and incubated for 90 rain at 37~  with end-to-end slow rotation. 
The resulting protoplasts were sedimented at 15,000 g for 30 min 
in a Sorvall centrifuge. The supernatant (crude extract) was dia- 
lyzed against 25 mM Tris/HC1, pH 8.5, 5 mM EDTA, concen- 
trated 10-fold  on a PM-10 membrane  (Amicon  Corp., Danvers, MA), 
and used for further purification. 
After lysin extraction, the pelleted protoplasts were resuspended 
and lysed in hypotonic buffer (2 ram sodium acetate, pH 5.5, con- 
taining 2 mM PMSF, 1 mM N-p-tosyl-t-lysine chloro-methyl ke- 
tone [TICK], 10 mM MgCh, and 10/~g/ml DNAse) followed 
by three freeze/thaw cycles. The membranes were then sedimented 
at 100,000 g for 45 min at 4~  The membrane pellet and cyto- 
plasmic extract in the supematant were analyzed  by Coomassie  blue 
stain after separation on an SDS gel. To determine the nature of 
association of the 39-kD protein with membranes, equal aliquots 
of the latter were suspended in 1.5 M sodium chloride or 100 mM 
sodium carbonate, pH 11.3 (2-3 mg total protein/ml) and placed 
on ice for 30 min (32). The suspensions were then centrifuged 
(100,000 g, 45 min, 4~  and the resulting pellets and superna- 
rants were checked for the presence of the 39-kD protein by SDS- 
PAGE and Western blot. 
To determine whether the 39-kD protein is surface  exposed, lysin 
extraction of trypsinized bacteria was carried out as described ear- 
lier (31, 32). Briefly,  washed bacteria were suspended in 100 ram 
NH4HCO3 and digested with trypsin (250/~g/ml)  at 37~  for 
3 h, after which the trypsin was inactivated by the addition of soy- 
bean trypsin inhibitor (200/~g/ml). Lysin extracts of trypsinized 
and control nontrypsinized bacteria were compared for the loss or 
reduction in the size of the 39-kD protein after SDS-PAGE and 
Western blot. 
Purification of 39-kD Protein.  The dialyzed and concentrated 
crude lysin extract was precipitated at a 60% saturation of ammo- 
nium sulfate at 4~  for 18 h. The precipitate was centrifuged at 
6,000g for 20 rain and the supernatant was brought to 85% satu- 
ration of ammonium sulfate. The resultant precipitate was again 
collected by centrifugation, resuspended  in 50 m125 mM Tris/HC1 
buffer, pH 8.5, dialyzed against the same buffer, and stored at 
-  70~  until further use. A 10-ml aliquot of this dialyzed precipi- 
tate was applied to a Mono Q FPLC column (1-ml bed volume) 
(Pharmacia LKB Biotechnology Inc., Piscataway,  NJ) equilibrated 
with the same buffer. After washing with five-column volumes 
of the starting buffer, bound proteins were eluted with a 50-ml 
linear NaC1 gradient from 0 to 300 raM. Fractions containing the 
39-kD protein, as determined by SDS-PAGE, were pooled and dia- 
lyzed against the 25  mM Tris/HCI/EDTA  starting  buffer and 
rechromatographed on the Mono Q column. The pooled fractions 
were concentrated to a volume of <1.0 ml using a Centricon con- 
centrator (cut off, 10,000 kD, Amicon Corp.). The concentrated 
sample (200-300/~1) was applied to a Superose 12 FPLC column 
(Pharmacia LKB Biotechnology Inc.) preequilibrated with 50 mM 
Tris/HC1, pH 8.5, containing 300 mM NaC1 and 5 mM EDTA. 
Fractions containing  the 39-kD protein were  pooled, dialyzed  against 
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and applied to a TSK-phenyl HPLC column (Bio-Rad Laborato- 
ties, Richmond, CA) preequilibrated in the same buffer. The pro- 
tein was  eluted by a  decreasing linear  gradient  of (NH4)2SO4 
from 1.0 to 0.0 M. The 39-kD protein was  eluted at 200 mM 
(NH4)~SO4. The purity of the final product was determined by 
Coomassie blue stain of the purified protein after SDS-PAGE and 
by analytical procedures described below. The purified protein was 
either stored at 4~  after dialyzing against 25 mM Tris/HCl, pH 
8.5, for various protein binding ~ents  or at - 70~  for longer 
storage. 
Analytical Procedures (NHrterminal Sequence and Amino  Acid 
Composition).  NHz-terminal amino acid sequence was determined 
according to the method of Matsudaira (33). Briefly, the purified 
39-kD protein was separated on a prelectrophoresed 10% SDS-PAGE 
gel under  nonreducing  conditions  and  transferred to  a  PVDF 
Immobilon-P filter presoaked in methand. Protein was visualized 
by staining with 0.05% Coomassie blue in a methanol/water/acetic 
acid (50:40:10)  solvent mixture. The blots were destained in the 
same ratio of methanol/water/acetic acid. The portion of the mem- 
brane containing the 39-kD protein band was excised and subjected 
to automated Edman degradation on a sequenator (A470; Applied 
Biosystems, Inc., Foster City, CA). Each sample applied to the SDS 
gel contained "~2-3/zg of Protein as determined by the BCA protein 
estimation method (Pierce Chemical Co., Rockford, IL). 
For amino acid composition, the PVDF membrane containing 
the 39-kD protein was stained with 0.1% Ponceau-S (Sigma Chem- 
ical Co.) in 1% acetic acid. The section of the membrane containing 
the protein band was excised and destained with water. This sec- 
tion of membrane was hydrolyzed in 6 N  HCI/0.1%  phenol at 
110~  for 22 h.  Amino acids were separated  on a Novapek C8 
column and analyzed using the Maxima software, 510 pump, and 
490 detector (Waters Associates, Milford, MA). Cysteine content 
was also analyzed from a PVDF membrane with bound 39-kD pro- 
tein carboxy amidomethylated with mercaptoethanol as described 
(34), and hydrolyzed and analyzed as described for amino acid anal- 
ysis. All analyses were performed by the Protein Biotechnology Fa- 
cility of The ILockefeller University. 
Molecular Mass Determination.  Molecular mass of the purified 
protein was determined in the laboratory of Mass Spectrometry 
and  Gas  Phase  Ion  Chemistry  of The  Rockefeller University 
using a modifed method of the mattix-assisted laser desorption 
technique (35). 
GAPDH Activity.  The assay for GAPDH activity was carried 
out according to the method originally described by Ferdinand (36) 
with minor modifications. Since GAPDH catalyzes  the oxidative 
phosphorylation of D-glyceraldehyde-3-phosphate  to  form,  1,3- 
diphosphoglycerate in  the  presence  of fl-nicotinamide adenine 
dinucleotide-positive (NAD +) and inorganic phosphate, the assay 
buffer was composed of triethanolamine (40 mM), Na2HPO4  (50 
raM), and EDTA (5 raM), pH 8.6. Disposable semi-micro (LS-ml 
capacity) spectrophotometer cuvettes (VWR Scientific) contained 
7/~1 glyceraldehyde-3-phosphate  (G-3-P) (49 mg/ml; Sigma Chem- 
ical Co.), 100/~1 NAD (10 raM; Boehringer Mannheim Biochem- 
icals), and assay buffer to a final volume of 1.0 ml after the addition 
of enzyme source resulting in a pH of 8.6. Different concentra- 
tions of the 39-kD protein were used to plot a standard curve for 
the absorbance at 340 nm/min as a measure of conversion of NAD 
to NADH using a Spectronic 3000 array spectrophotometer (Milton 
Roy, Rochester, NY). 
Enzyme Kinetics.  Kinetics of the enzymatic activity of the 39- 
kD protein (25/zg) was determined with varying concentrations 
of G-3-P with a fixed concentration of NAD and vice versa to, 
respectively,  determine the Km and Vmax for G-3-P and NAD. 
The results were recorded as the rate analysis of NADH release 
at 0.5-s intervals for a period of 1 rain at 340 nm. The molar ex- 
tinction coef~cient of NADH (6.22  ￿  10  ~ [37]) was used to con- 
vert absorbance (340 nm)/min to M  NADH/min.  The kinetics 
coef~cients (Km) were calculated from the values obtained for the 
intercepts and slopes of the double reciprocal plots of Lineweaver 
and Burk (38) with respect to each substrate.  The specific activity 
of the enzyme (U/mg) was measured using the equation: specific 
activity ~  v(1  +  Km/S)NAD (1  +  Km/S)c~3_p, where v  =  /~mol 
NADH/min/mg  of enzyme. 
The GAPDH activity for the 39-kD protein was measured in 
the lysin extract, dialyzed ammonium sulfate precipitate, and pooled 
fraction at various purification stages. 
Rabbit Immunization and Affinity Purification of Immune Sera. 
New Zealand white rabbits were immunized subcutaneously with 
200/zg of the purified 39-kD protein emulsified  in CFA (1:1) at 
multiple sites. Rabbits were boosted once with 200/~g of the Pro- 
rein in IFA (1:1) 30 d later. Rabbits were bled 10 d after the second 
immunization. All sera were filter sterilized and stored at 4~ 
39-kD-specific antibodies were affinity purified from the poly- 
clonal sera on columns containing 2.0 mg of the purified 39-kD 
protein linked covahntly to glutaradialdebyde activated beads  as 
described (39).  Anti-39-kD protein antiserum (2-3 ml) was  ad- 
sorbed to and eluted from the immunoadsorbent column, dialyzed, 
concentrated, and stored as described (39).  The antibodies were 
further purified on a protein A-Sepharose column (Pharmacia LKB 
Biotechnology Inc.)  essentially  as  described  (39).  The  mono- 
specificity of the antibody was checked against crude lysin extracts 
by Western blot as described below. 
Dot-Blot Immunoassay to Determine the Location of the 39-kD Pro- 
tein.  The surface location of 39-kD protein was determined with 
the monospecific antibodies using a bacterial dot-blot immunoassay 
as previously described (31, 40). Essentially,  an overnight culture 
of strain D471 was adjusted to ODium 1.0 with 50 mM Tris/HC1 
buffer, pH 8.5. Aliquots of this suspension  were centrifuged and 
resuspended to the same volume of buffer containing either 2 M 
NaC1 or 2% SDS, and rotated at room temperature for I h, cen- 
trifuged, and the respective supernatants  were saved. After washing, 
the  pellets  were again  adjusted  to OD~s0 nm 1.0  with  50  mM 
Tris/HC1 buffer, pH 8.5. In a separate experiment, the bacterial 
suspension  in the Tris/HC1 buffer was centrifuged, and the bac- 
teria were suspended in 100 mM NH4HCO3 to OD6s0 nm 1.0 and 
treated with trypsin (250/~g/ml) for 3 h at 37~  Trypsin activity 
was inhibited with trypsin inhibitor as described above, and the 
bacteria were pelleted and resuspended in the Tris/HC1 buffer to 
OD6s0 m  1.0.  50/~1 of each bacterial suspension  was transferred 
to nitrocellulose paper using dot-blot assembly (Bio-Rad Labora- 
tories, Richmond, CA). Reactivity of surface-exposed epitopes of 
the 39-kD protein was determined using af~nity-purified anti-39- 
kD protein antibodies (1:1,000 dilution of 0.5 mg/ml stock) as de- 
scribed previously (31). For densitometric analysis of the dot blot, 
a duplicate blot was developed with Lumi-Phos~530 (adamantyl- 
1,2-dioxetane phenyl phosphate; Lumigen Inc., Detroit, MI), which 
undergoes enzyme (alkaline phosphatase)-catalyzed dephosphory- 
lation to form a dioxetane anion that is converted ultimately into 
an excited state of the methyl meta-oxybenzoate anion, the light 
emitter (41). The developer was then drained off, and the wet blot 
wrapped in Saran Wrap was exposed to x-ray film for 20 min and 
developed using conventional procedures. Densitometric analysis 
of each spot on the x-ray film was carried out on an image analyzer 
using the Dumas program (Drexel University, Philadelphia,  PA) 
interfaced with IBM computer. 
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developed to determine whether the 39-kD protein on the surface 
of streptococci functions as an active GAPDH enzyme. Different 
concentrations of  trypsinized (as described above) and nontrypsinized 
streptococci were incubated with and without G-3-P in the pres- 
ence of NAD in triethanolamine-phosphate-EDTA dithiothreitol 
(DTT) buffer as described above. The reaction was allowed to occur 
in a final volume of 1.0 ml for a period of 2 rain at room tempera- 
ture, after which the bacteria were removed by centrifugation. The 
supernatants were analyzed for the conversion of NAD to NADH 
by recording the absorbance at 340 nm as described above. This 
enzymatic activity was also determined on streptococci preincubated 
with a 1:50 dilution of a 0.5 mg/ml stock of affinity-purified  anti- 
39-kD protein antibodies to examine the inhibition of enzymatic 
activity. 
PAGE and Western Blotting.  Electrophoresis and Western blot- 
ting of protein samples were carried out as described before (31, 
32). Specific proteins bound to the nitrocellulose membrane were 
probed and visualized with affinity-purified anti-39-kD protein an- 
tibodies (1:2,000 dilution of 0.5 mg/ml stock) as described previ- 
ously (31, 32). 
Presence of a 39-kD Protein on l~'fferent Streptococcal M  Serotypes 
and Streptococcal Groups.  Lysin extracts of M serotypes 2, 4, 5, 6, 
24,  29,  41,  57,  58,  60,  and M-  were prepared as described (31, 
32). The muralytic enzyme mutanolysin (20/~g/ml; Sigma Chem- 
ical Co.) was used to prepare cell wall extracts of each grouping 
strain suspended in 50 mM Tris/HC1 buffer, pH 6.8, containing 
5 raM EDTA, 5 mM MgC12, and 30%  raffinose, and incubated 
at 37~  for 60 min under constant end-to-end rotation. Proteins 
in all the extracts were separated  on SDS-PAGE and transferred 
to nitrocellulose.  The blots were probed with affinity-purified anti- 
39-kD protein antibodies as described above. 
Relationship of GAPDH frorn Bacterial and Mammalian  Origins 
with the 39-led Protein. The crossreactivity of  GAPDHs isolated from 
rabbit skeletal muscle,  human erythrocytes, and Bacillus stearother- 
rnophilus were determined both by Western blot and competitive 
ELISA  (described  below). 
ELISA and Competitive Inhibition.  ELISA was performed as de- 
scribed earlier (42), except that ELISA plates were coated with 100 
/~l/weil of 1/~g/ml of purified 39-kD protein for 3 h at 37~  and 
then overnight at 4~ 
Competition ELISA was used to determine the relationship of 
GAPDH molecules from bacterial and mammalian origin with the 
39-kD protein by methods described previously (40). Briefly, com- 
peting GAPDHs were serially diluted in 10 mM sodium phosphate, 
pH 7.4, containing 0.05%  Brij-35  (40)  starting with  100 times 
molar  excess relative  to  the  39-kD  protein  coating  the  plates. 
Affinity-purified antibodies to the 39-kD protein were adjusted  to 
a dilution resulting in an ELISA reading of 1.0 at 405 nm after 
60 rain. Antibodies diluted in this way were then added to each 
well and the plates processed for kinetic ELISA analysis as described 
(42) using an ELIDA-5 microtiter plate reader (Physica Inc., New 
York,  NY). 
Radioiodination of  Proteins.  The 39-kD protein (400/~g) was la- 
beled  with  tzsI by  the  chloramine-T  method  using  Iodobeads 
(Pierce Chemical Co., Rockford, IL). The labeled protein was sepa- 
rated from free iodine by filtration over a column of  Sephadex G-25 
(PD-10;  Pharmacia LKB Biotechnology Inc.) and collected in 100 
mM phosphate buffer saline, pH 6.5. The labeled protein was stored 
at  -20~  in aliquots containing 0.02% NAN3. pibronectin and 
plasmin were labeled essentially by the same method. The specific 
activity of the 39-kD protein, fibronectin, and plasmin after labeling 
was 2  x  106, 1.0  x  106, and  1.21  x  106 cpm//~g, respectively. 
Binding  Studies.  The binding activity of the 39-kD protein, 
fibronectin, and plasmin was determined by the use of the 112s- 
labeled proteins. Egg white-lysozyme and/or cytoskeletal proteins 
(myosin, heavy meromycin [HMM], light chain myosin [LMM], 
tropomyosin, and actin) and streptococcal M protein (43) were sepa- 
rated on 10% SDS-PAGE gels and dectroblotted onto nitrocellu- 
lose paper.  The blots were blocked in 10 mM Hepes buffer con- 
taining  150 mM NaCI,  10 mM MgCI2,  2  mM CaClz,  50 mM 
KC1, 0.5% Tween-20, 0.04% NuNs, and 0.5% BSA, pH 7.4, for 
2-3 h at room temperature, and probed for 3-4 h at room tempera- 
ture in the same buffer containing 12sI-fibronectin, lzsI-39-kD pro- 
tein,  or  12sI-plasmin adjusted  to 3  x  10  s cpm/ml.  The probed 
blots were then washed three to four times with blocking buffer, 
dried, and exposed to Kodak Blue Brand film with an intensifying 
screen  for 36-48 h  at  -70~ 
Results 
Digestion of the streptococcal ceil wall with lysin at pH 
6.1 in the presence of 30% rafiinose results in the release of 
M  protein (31, 32). SDS-PAGE of an M6 streptococci lysin 
extract indicates that in addition to the M protein, a number 
of other proteins are found in the ceil wall digest,  some at 
an apparent higher concentration than the M molecule based 
on Coomassie blue staining (Fig. 1, lane a). To further char- 
acterize these other walbassociated proteins, we first selected 
the molecule at  39 kD. 
Purification  of the 39-kD Protein.  The 39-kD molectfle was 
partially purified from the crude lysin extract (Fig.  1,  lane 
a) by ammonium sttlfate precipitation (lanes b and c), Mono Q 
ion-exchange chromatography (lane d), and molecular sieve 
chromatography on a Superose 12 column (lane e). Remaining 
contaminants  were separated from the 39-kD  molecule by 
hydrophobic chromatography. SDS-PAGE of the final purified 
preparation revealed a homogeneous protein with a molec- 
ular mass of 39 k19 (Fig. 1, lane  f). The total yield of purified 
protein from 4 liters of culture representing 6-8 g wet weight 
of bacteria was 800/zg. The peak elution volume of the 39-kD 
protein on a Superose 12 column was the same for IgG (150 
kD) (data not shown),  suggesting  that either the molecule 
Figure 1.  SDS-polyacrylamide 
gel (10%) analysis of the 39-kD 
protein  from  M6  streptococci. 
Lane a,  Lysin extract  of D471 
streptococci;  lane b, precipitate  of 
65%  (NH4)2SO4 saturation  of 
the lysin e~tract; lane c, precipi- 
tate of 85%  (NH4)2SO4 satura- 
tion  of  the  supernatant  after 
65% precipitation;  lane d, pooled 
Mono Q fractions at 0.28 M gra- 
dient  ehtion;  lane e,  partially 
purified 39-kD protein from the 
Superose 12 column; lane./, puri- 
fied 39-kD protein from Pheny] 
TSK column. Arrows on lanes a and b at 50 kD indicate the position of 
M protein. Prestained  marker protein mixture with M,S (subunit molec- 
ular mass) as indicated on the left margin. 200 kD, myosin (H chain); 
97.4 kD, phosphoryhse b; 68 kD, BSA; 43 kD, OVA; 29 kD, carbonic 
anhydrase; 18.0 kD, lactoglobulin; 14.3 kD, egg-white lysozyme. 
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Figttrr 2.  (a) The NH2-terminal 
sequence of  the  39-kD  (SDH) 
protein.  (b)  Comparison  of the 
NHz-terminal amino acid sequence 
of the  39-kD  protein with  the 
amino acid sequences of  the known 
GAPDH molecules obtained from 
the  translated  GenBank  data- 
base. BstGAP,  Bacillus stearothermo- 
ph/hs GAPDH; EcoGAP,  Escher/ch/a 
coil  GAPDH;  HumGAP,  hu- 
man GAPDH; ChkGAP, chicken 
GAPDH; StoP37, Schistosomia man. 
soni 37-kD protein (GAPDH) (55); 
ZmbGAP,  Zymomonas  mobilis 
GAPDH.  Numbers on the right 
side of the figure indicate the per- 
centage similarity of the  39-kD 
(SDH) protein with other GAPDH 
molecules with residues 1-18 and 
1-39. The gap(-) between the 14th 
and  15th residue of the  chicken 
GAPDH sequence was introduced 
to maximize homology. 
exists as a tetramer or it behaves anomalously on a molecular 
sieve. 
NHz-terminal Sequence and  Amino  Acid Composition. 
NHz-terminal amino acid sequence analysis of the purified 
39-kD protein confirmed the homogeneity of the prepara- 
tion resulting in a single amino acid at nearly all positions 
(Fig.  2 a). Except for positions 31 and 35, a single amino 
acid was identified in the first 35 residues with the remaining 
four tentatively identified because of the low yidd. 
The amino acid composition of the purified protein indi- 
cated a high content of Asp/Asn (12.1%), followed by Ala 
(10.7%), Gly (10.3%), Val (10.2%), and Glu/Gln (8.4%). 
The mass of the purified protein (35,882  daltons) as deter- 
mined by laser desorption mass-spectrometry was used to more 
precisely assign the number of residues/mol (Table 1). 
Amino Acid Sequence  and Composition Comparison.  When 
the sequence of the first 39 amino acids of the 39-kD protein 
was compared to known sequences in the translated Gen- 
Bank database (Fig. 2 b), significant identity was found with 
bacterial and eukaryotic GAPDHs. The identity within the 
first 18 residues was 77-83% with bacterial,  eukaryotic, or 
fungal GAPDHs. This strong homology decreased over the 
remaining 21 residues with an overall identity of oo41-56% 
(Fig. 2  b). 
When the amino acid compositions of the various GAPDHs 
were compared, the methionine content of the 39-kD pro- 
tein was found to be significantly low (1.8 residue/tool) with 
relation to the eukaryotic (8.4 residue/tool) or other bacterial 
GAPDHs (7 residues/mol) (Table 1). Although the amino 
acid compositions of the remaining residues  of the 39-kD 
protein were found to be relatively close to that of the other 
GAPDHs, sufficient differences were found that suggest that, 
except for the NH2-terminal sequence, the streptococcal pro- 
tein may be structurally different from reported GAPDHs. 
GAPDH Activity of the 39-kD Protein.  The strong NH2- 
terminal sequence homology of the purified 39-kD protein 
with GAPDH prompted us to check whether the protein 
possessed any GAPDH activity. In the presence of G-3-P in 
triethanolamine buffer at pH 8.6, the 39-kD protein showed 
a dose-dependent conversion of NAD to NADH, as observed 
by absorbance  of the latter at 340 nm. A variation of the 
enzyme reaction rate with different concentrations of G-3-P 
and NAD was determined using 25/~g of the purified 39- 
kD protein. The results were analyzed both as Michaelis- 
Menten and double reciprocal plots according to Lineweaver 
and Burk (38) as shown in Fig. 3, a and b. From these plots 
the Km for G-3-P and NAD was estimated to be 1.33 mM 
and 156.7/~M, respectively, and Vm~, was 0.487  x  10 -3 M 
NADH/min. The specific activity (34 U/mg) of a typical 
run of purified 39-kD protein was calculated using Ferdinand's 
equation (36):  1.91  x  v, where v is/~M NADH/min/mg. 
Tetrameric Structure.  From the anomalous behavior of the 
39-kD protein on a Superose 12 molecular sieve suggesting 
a molecule four times larger than that observed by SDS-PAGE 
and the fact that functional GAPDH molecules are tetrameric 
structures, we reasoned that the 39-kD protein may be seen 
under mild denaturing condition. To examine this, SDS-PAGE 
was performed with the 39-kD protein saturated with NAD 
to stabilize the complex in a sample buffer containing no SDS 
or B-mercaptoethanol and without boiling; however,  SDS 
was present in the gel and running buffer. Under these con- 
ditions, a major protein band was found at 39 kD with a 
minor band at 150 kD by Coomassie stain (Fig. 4 A). This 
finding was further confirmed  by Western blot using affinity- 
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Table  1.  Comparision  of Amino Acid Composition of SDH 
Protein from M  Type 6 Streptococci with That of GAPDH from 
Different Species 
No. of residues/tool 
SDH*  BSt  Thaq  RSM 
Amino acid  (35.8)*  (36.0)  (36.0)  (34.0) 
Ash/Asp  43.3  41  36  35.5 
Glu/Gln  29.9  26  24  18.7 
Set  16.8  17  13  19.7 
Gly  36.6  24  25  31.7 
His  7.2  9  10  9.8 
Arg  15.5  15  15  10.1 
Thr  27.0  18  22  21.6 
Ala  38.1  38  41  32.6 
Pro  13,6  11  12  11.9 
Tyr  9.1  8  10  8.6 
VaI  36.5  43  29  31.2 
Met  1.8  7  7  8.4 
Ile  22.4  19  22  15.3 
Leu  23.4  26  30  17.8 
Phe  13.8  5  7  12.9 
Lys  21.4  23  23  23.9 
CysS  3.1s  2  1  3.0 
Trp  ND  2  3  ND 
Bst, B. stearotherraophilus (52); Thaq, Thermus aquaticus  (52); RSM, Rab- 
bit skeletal muscle (9). 
* Mean of three determinations. 
* Molecular mass of SDH protein (35,882) was measured by laser desorp- 
tion mass spectrometry. 
$ Determined by carboxy amidomethylation  method (34). 
purified anti-39-kD protein antibodies, which reacts only with 
the 39-kD protein in a crude lysin extract (Fig.  4 B). Taken 
together, these findings suggest that a tetrameric form of the 
39-kD protein may be the native state of the molecule on 
the streptococcal cell surface. 
Location of the  39-kD  Protein on  the  Streptococcal Cell, 
A~nity-purified anti-39-kD protein antibodies were used in 
a dot-blot immunoassay using whole streptococci to deter- 
mine the location of the protein. Trypsin treatment of  whole 
streptococci resulted in a marked reduction in their reactivity 
to anti-39-kD antibodies (Fig.  5).  The inability to remove 
the 39-kD protein from the streptococcal surface after washing 
in 2 M  NaC1 or 2% SDS (Fig.  5) indicates that the protein 
is not peripherally associated  but tightly bound to the cell. 
These data indicate that the 39-kD protein is a surfar,  e GAPDH 
molecule on the streptococcal cell, which we hereafter term 
SDH. 
GAPDH Activity of Whole Streptococci.  To determine if 
the GAPDH activity of SDH was also present on the strep- 
tococcal surface,  enzymatic studies were carried out using 
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Figure 3.  Lineweav~-Burk's  double  reciprocal  kinetic  analysis  of  GAPDH 
activity of the 39-kD protein. (a) 25 #g of 39-kD protein was assayed 
as a function  of  G-3-P in the presence  of  NAD (100  #M) in triethanolamine- 
phosphate-EDTA-DTT  buffer  at pH 8.6. The Km for G-3-P  was estimated 
to be 1.33 raM; Vm=, 0.487 x  10-3 M NADH/min; intercept on 2/- 
axis(1/Vm,~), 2.05; and slope (Km/Vm~), 2.73. The inset shows the anal- 
ysis based on the method  of Michaelis-Menten. Km, 1.22 raM; and Vm~, 
0.466  X 10 -3 M NADH/min. (b) 25/~g of the 39-kD protein was as- 
sayed  as a function  of  NAD in the presence  of  G-3-P (2 raM) in the buffer 
system as described  in a. The Km for NAD was estimated to be 156.7 
#M; V~,~, 0.459 x  10 -3 M NADH/min; intercept  on y-axis(1/V~=), 
2.18; and slope (Km/V=~,), 341.74. Km for NAD by the method of 
Michaelis-Menten as shown in the inset was estimated to be 148.86/~M; 
and Vm~, 0.445 X 10 -3 M NADH/min. 
whole streptococci. The same concentration of substrates 
(G-3-P and NAg)) employed with the purified SDH protein 
were used with whole streptococci. Data presented in Fig. 
6 a reveal a dose-dependent GAPDH activity catalyzed by 
the whole organisms. As found with the purified SDH pro- 
tein, the intact bacteria also did not catalyze the reaction in 
the absence of the substrate G-3-P in the presence of NAD 
(Fig. 6 a). The enzymatic activity was significantly decreased 
(80%) when trypsinized bacteria were used in the reaction 
mixture (Fig. 6 b). The background 20% activity may repre- 
sent an incomplete digestion of the SDH protein by trypsin. 
The enzymatic activity on the whole organisms was also found 
to be partially (30%) but specifically inhibitable by the anti- 
SDH antibodies (Fig.  6 c). 
420  A Major Surface Protein on Group A Streptococci Figure 4.  (A) Coomassie blue stain of SDS-gel and (B) Western-blot 
analysis of the 39-kD protein with affinity-purified anti-39-kD protein an- 
tibodies suggesting a muhimeric structure for the 39-kD molecule. Lanes 
a and d, crude lysin extract; hnes b and e, purified 39-kD protein;  lanes 
c and f, unboiled purified 39-kD protein in sample buffer without SDS 
and saturated with NAD. Arrow indicates the position of a molecule of 
the size consistent with a tetrameric form of the 39-kD protein.  For de- 
tails of each molecular mass marker on the left,  see Fig. 1. 
Prevalence  of  SDH in Otker  M Serot~es and Gwups of  Strep- 
tococci.  The presence of the SDH protein in different strep- 
tococcal M serotypes was determined  by Western blot analysis 
of lysin extracts using afffinity-purified  anti-SDH antibodies. 
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Figure 6.  GAPDH activity of whole streptococci. (a) The GAPDH ac- 
tivity was observed at 340 nm of whole M6 streptococci by determining 
the conversion of NAD to NADH in the presence of G-3-P. Details of 
the buffer system are described in materials and methods.  (b) Activity of 
trypsinized M6 streptococci. (c) Inhibition  of enzyme activity by affinity- 
purified anti-SDH  antibodies (1:20 of  0.5 mg/ml for 3 h at room tempera- 
ture).  Each bar represent the mean of three  separate readings  _+  SD. 
As shown in Fig.  7 A,  a similar high concentration  of the 
SDH  protein was found in  all  the  serotypes  tested,  even  a 
strain  defined as M  protein negative based on an extensive 
genetic  ddetion  (30).  Furthermore,  all reactive bands were 
found to be of the same apparent molecular size as the purified 
SDH  molecule  without  any obvious indication  of hetero- 
geneity. 
Figure 5.  Dot blot immunoanalysis to locate the 39-kD protein on the 
streptococcal surface~ The assay  detemfines the ~r  of  n~ctivity  of  affinity- 
purified anti-39-kD protein antibodies to surface exposed protein before 
and after 2% SDS, 2 M NaCI, and trypsin treatments.  Dot blots were 
treated with LumiPhos-530 substrate (41) and developed on x-ray film. 
Densitometric  reading of the image obtained on the x-ray film was ex- 
pressed as an optical density in terms of arbitrary units measured on an 
image analyzer using the Dumas program (Drexel University, Phihdd- 
phia, PA). An internal  linear standard curve for the OD 0.008-1.333 was 
obtained for final densitometric analysis  of the dot blot. Each bar represents 
the mean of four to eight separate readings  +_  S.D. 
Figure 7.  (A) Western blot analysis of lysin extract of various strep- 
tococcal M types with at~inity-purified  anti-SDH antibodies at a 1:2,000 
dilution of 0.5 mg/ml stock. Purified SDH and an M negative (M-) strep- 
tococci are also included  in the analysis. (B)  Western  blot analysis of 
mutanolysin  extract os various grouping of streptococci using anti-SDH 
antibodies as described in (A). 
421  Pancholi and Fischetti Figur|  8.  Competition  kELISA  with immobilized  SDH protein. Com- 
mercially available purified GAPDH from/~  stearothermophilus,  human 
etythroey~ and rabbit skeletal  muscle  veeae  used  to compete  for the binding 
of affinity-purified anti-SDH antibodies (1:1,000 dilution of 0.5 mg/ml 
stock). Each curve  represents the mean  of  three separate  experiments with 
<5% SD (not shown). Inset shows  the Western blot of the reactivity of 
al~nity-purified anti-SDH antibodies with (a) streptococcal SDH and 
GAPDHs of (b) bacterial (B. stearotherraophilus),  (c) rabbit skeletal muscle, 
and (d) human erythrocytes. 
Since the lysin enzyme does not act on all streptococcal 
cell walls,  the presence of SDH protein  in different  strep- 
tococcal grouping strains was seen in their respective muta- 
nolysin extract. The results of Western blot analysis  shown 
in Fig.  7 B reveal  that  the SDH protein was also found in 
mutanolysin  extracts of all the grouping  strains  examined, 
except groups D,  F, and N.  The reactivity of an SDH-like 
protein in the group H extract was found to be weaker when 
compared with  that  of the others. 
Relationship of  SDH with GAPDHs of  Bacterial, Animal, and 
Human  Origin.  The  relationship  of  SDH  with  known 
GAPDHs was determined by both Western blot and com- 
petitive kinetic (k) ELISA using affinity-purified anti-SDH 
antibodies.  Western blot analysis with SDH-specific antibodies 
revealed that GAPDH from bacillus, human RBCs, and rabbit 
muscle reacted weakly or not at all (Fig. 8, inset). This finding 
was further confirmed by competition F_LISA  (Fig. 8) showing 
that  only a maximum  of 20--25 %  inhibition  of binding  of 
anti-SDH antibodies to SDH could be achieved with 100 molar 
excess of these proteins, with the rabbit muscle GAPDH ex- 
hibiting the least activity. The fact that almost 20% inhibi- 
tion is observed with <20 times molar excess of bacillus and 
human GAPDH may reflect the sequence homology observed 
at  the  NH2 termini  of these molecules (Fig.  2). 
Binding  of SDH  to  Cytoskeletal  Proteins,  Lysozyme,  and 
Fibroneain.  Since many glycolytic enzymes have been shown 
to specifically  bind cytoskeletal proteins  (8,  44),  we exam- 
ined  whether  SDH  has  a  similar  property.  12sI-SDH  was 
used to probe a Western blot containing several cytoskeletal 
proteins.  The results revealed a specific  binding  to myosin 
(Fig.  9, A  and B, lanes a)  and its  globular domain  (heavy 
meromyosin)  (lanes  b) and  actin  (lanes d),  but not  to  the 
c~-helical domain  of myosin  (light  meromyosin)  (lanes  c), 
tropomyosin (lanes  e), or streptococcal M protein (lanes f). 
In  addition  to  the  above proteins,  the  125I-SDH was  also 
found to strongly bind to lysozyme (Fig.  9, lanes g).  Since 
a fibronectin binding property has been reported to be present 
on  this  streptococcal  strain  (5),  we  tested  the  fibronectin 
binding activity of the SDH protein using either mI-labeled 
fibronectin or fibronectin-anti-fibronectin on a Western blot. 
Figure 9.  Binding of lzq-SDH 
to cytoskeletal proteins. (A) Co- 
omassie  blue-stained  SDS-PAGE  gel 
(10%) containing 5 pg protein of 
various cytoskeletal  proteins, lyso- 
zyme, and M6 protein (43). Lane 
a,  rabbit skeletal myosin; lane b, 
heavy meromyosin; lane c,  light 
meromyosin; lane d, actin; lane e, 
M6 protein; lane  f, S-2 fragment of 
heavy meromyosin; lane g,  egg 
white  lysozyme. (B)  Autoradio- 
graph of proteins in a duplicate  gel 
after tranfftr onto nitrocellulose  and 
incubation with the I~I-SDH. The 
proteins in each lane are described 
in A. For details of each molecular 
mass marker on the left, see Fig. 1. 
422  A Major Surface Protein on Group A Streptococci Figure 10.  Binding activity of SDH to fibronectin.  (A) Coomassie stain 
of an SDS gel containing 5/tg of SDH and BSA. (/3) Western blot analysis 
of  a  duplicate  gel  showing  the  binding  of  fibronectin  followed by 
antifibronectin to the SDH molecule. (C) Autoradiograph of a similar 
Western blot showing the binding of 12sI-fibronectin to the SDH pro- 
rein. Lanes a, c,  and e, SDH;  lanes  b, d, and f,  BSA. 
The results revealed that fibronectin bound specifically  to SDH 
and not to BSA in both assays (Fig.  10). 
Discussion 
Because one of the sites of the primary infection by group 
A streptococci is the pharynx, it is likely that initial events 
involve an interaction of the organism with salivary compo- 
nents before attachment to pharyngeal epithdial cells, par- 
ticularly the tonsiUar mucosa. These initial events ultimately 
result in the colonization and subsequent infection of the target 
tissue.  It is, however,  unknown which surface molecule(s) 
play a role in one or more of these early events. In the present 
study, we have focused our attention on a 39-kD surface pro- 
tein that comprises a significant  amount of the total protein 
found in a lysin extract of whole streptococcal cells. This md- 
ecnle is found at concentrations higher than the surface M 
protein in this and other streptococci examined. Because of 
its relatively high level of expression on the cell surface, and 
recent evidence (5, 6) indicating that neither M protein nor 
LTA alone or in combination take part in adherence to pha- 
ryngeal epithdial cells, we examined the characteristics of this 
surface protein in the hope to understand its role (if any) in 
the colonization and/or infection process. 
The 39-kD protein was pttfified to homogeneity  from strep- 
tococcal cell wall extracts  and its NHz-terminal sequence 
compared with sequences collected in the translated GenBank 
database.  Over 80%  of the NHz-terminal  18 of 39 amino 
acids were identical to the GAPDH family of enzymes. The 
enzymatic activity of the puri~ed protein was verified by stan- 
dard assays  for GAPDH activity. A specific  activity of 34 U/mg 
of purified protein was found to be comparable to other 
reported GAPDH enzymes (11, 45, 46). SDS gel electropho- 
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resis and Western blot analyses of the unhoiled SDH protein 
sample containing no SDS and saturated with NAD to stabi- 
lize the tetrameric structure (47) indicated the presence of 
a protein band in a position consistent with a molecule of 
150 kD, as found for the SDH by molecular sieve chroma- 
tography (Fig. 4). This molecular form could not be seen 
using a standard SDS sample buffer without reducing agent, 
suggesting that the subunits are not held by snlfhydryl  bonds 
despite the presence  of three cysteine residues/mole (Table 
1). The heat stability of the tetrameric structure of GAPDHs 
from thermophilic  bacillus species compared with those from 
eukaryotes and SDH can be attributed to the presence of extra 
ionic bonds located between the enzyme subunits of the ba- 
cillus GAPDH enzymes (48).  Since the enzymatic activity 
of GAPDH is dependent upon its tetrameric structure, the 
GAPDH activity of whole streptococci support the idea that 
the SDH may also exist as a tetramer on the streptococcal 
surface. 
The Km for G-3-P (1.33 mM) in the present investigation 
is about the same magnitude as was found for GAPDH from 
B. stearothermophilus  (1.0 mM) (46), but 22 times higher than 
rabbit muscle GAPDH (60/xM) (45) and up to 238 times 
higher than that reported for GAPDH from human erythro- 
cytes (5.6/tM) (11). Similarly, the Km for NAD (156.7/~M) 
of SDH was ,,02.4 times that for R stearothermophihs  (66 ~M) 
(46) or only 1.5-4-fold higher than reported for GAPDH 
enzymes from rabbit muscle (45)  and human erythrocytes 
(11). This finding possibly reflects a conservation within the 
NAD binding domain, which is located at  the NH2 ter- 
minus of the GAPDH molecule, and limited conservation 
within the catalytic domain as reported recently by Ndson 
et al. (49). The strong NHz-terminal sequence similarity of 
the SDH protein with other GAPDHs supports the idea. 
It is not possible to make further predications regarding the 
structure of this protein without the complete amino add 
sequen~ However, amino add composition comparison with 
other GAPDH mdecules reveals sut~cient homology to pre- 
dict a certain degree of relatedness but indicates  that SDH 
is likely to be structurally distinct from other known GAPDH 
molecules. This difference was verified by Western blot indi- 
cating a weak reactivity of anti-SDH antibodies with known 
GAPDH  molecules. Furthe~rr,  ore,  solid-phase  competitive 
kELISA, at up to 100 times molar excess of bacillus and eu- 
karyotic GAPDHs, revealed only 20--25% inhibition of  reac- 
tivity of anti-SDH with SDH, confirming its limited relat- 
edness with GAPDHs of both bacillus and eukaryotic origin, 
possibly confined to the NHz-terminal region of these mol- 
ecules. The NH2-terminal sequence of the SDH protein re- 
vealed  the  presence  of a  motif (GlyS-X-Glyl~  13) 
(Fig. 2) found in other GAPDHs and shown to be a putative 
ATP-binding domain (50). By Western blots, [3ZP]ATP  was 
found  to  bind  to  eukaryotic  GAPDHs  but  not  bacillus 
GAPDH or the SDH protein (data not shown). Since both 
eukaryote and prokaryote GAPDH molecules have the same 
motif, the difference in ATP binding may reflect variations 
found in the regions flanking the motif (Fig.  2  b). 
Historically,  GAPDH is known to be a cytoplasmic en- 
zyme.  However,  recent  reports  (9-12)  have  shown  that GAPDH from eukaryotes may also be merabrane bound. SDH 
was isolated from the lysin extract of streptococci that repre- 
sent mainly surface located proteins. This was confirmed by 
its  sensitivity to  trypsin digestion of whole streptococci 
resulting in both the loss of the 39-kD band from the lysin 
extract, and a significant decrease in the anti-SDH antibodies 
reactivity of whole streptococci. The inability of 2% SDS 
or 2 M NaC1 to remove the SDH protein from intact strep- 
tococci suggests that, like M protein (51), SDH is firmly bound 
to the cell and is not peripherally associated,  however,  the 
nature of its cell attachment is not apparent.  In bacteria, 
GAPDH has been reported and purified from cytoplasmic 
fractions (52), however, there have been no reports of an ac- 
tive enzyme on a  bacterial  surface.  Detection of a  dose- 
dependent GAPDH activity of intact streptococci in pres- 
ence of the appropriate substrates dearly indicates that SDH 
is enzymatically active on the streptococcal surface. Only a 
small quantity of protein reactive with the anti-SDH anti- 
bodies by Western blot was seen in the growth supernatant 
after 50-fold concentration (data not shown), demonstrating 
that the SDH is not a secretory product of the group A strep- 
tococcus. 
Recently, a strong plasmin binding protein from group 
A streptococci (53) was reported to have extensive sequence 
homology with GAPDH (54). Using radiolabeled plasmin, 
we were able to detect weak binding to the SDH molecule 
by Western blot, indicating that SDH may be different from 
the  reported strong plasmin binding molecule (data  not 
shown). Although the GAPDH enzymatic activity of the 
strong plasmin binding molecule was not determined (53, 
54) its homology with GAPDH may suggest that a family 
of related molecules may exist on the streptococcal surface. 
It is conceivable that the surface-bound forms of GAPDHs 
are subject to sequence variation to perform functions in ad- 
dition to their NHrterminal dehydrogenase activity,  while 
cytoplasmic forms of GAPDH may remain more conserved 
throughout the molecule. 
Goudot-Crozel et al. (55) recently presented evidence for 
an active GAPDH on the surface ofSchistosoma mansoni. They 
showed that sera from subjects with low susceptibility to in- 
fection by this parasite reacted with this protein while sera 
of susceptible individuals had little or no activity. They pro- 
posed that human T cell response to GAPDH would be ge- 
netically restricted resulting in a population of nonresponders 
to this protein, allowing the parasite to have an increased chance 
to  infect.  Although  this  hypothesis requires  further  ex- 
perimental support, in terms of the current finding it may 
shed some light on the pathogenesis of streptococcal infec- 
tions and associated  sequelae. 
Western blot analysis of lysin extracts from different strep- 
tococcal M types revealed the presence of SDH in all the M 
types tested with no observed size heterogeneity as found 
with the M protein. The ubiquitous nature of the SDH pro- 
tein among group A  streptococci along with its relatively 
high concentration may reflect a common and perhaps ira- 
portant function for the organism. This ubiquitous nature 
was found to a limited extent among different groups of strep- 
tococci. The absence  of anti-SDH-reactive protein in the 
mutanolysin extracts of streptococcal groups D, F, and N in- 
dicates either the complete lack of this protein or presence 
of antigenicaUy unrelated SDH-like molecule. 
To determine if the SDH protein plays a role in the early 
events of infection, we examined its relationship to a recently 
reported fibronectin binding protein found on the surface of 
group A  streptococci (6).  We discovered that 12sI-SDH is 
able to bind to both fibronectin and lysozyme by Western 
blot. Whether this attachment to fibronectin is mediated by 
an RGD sequence or another specific sequence motif (56) 
will demand additional sequence data.  Because lysozyme is 
a polycationic molecule, the observed binding of SDH to this 
protein may be charge dependent. However,  the possibility 
that the strong binding between these two molecules may 
be mediated by a specific sequence motif can not be excluded. 
Since SDH binds to both fibronectin and lysozyme, and both 
are found in soluble form in saliva as well as plasma, they 
may influence the streptococcal  surface during colonization 
and/or infection. 
Many  glycolytic enzymes such as  aldolase,  lactate  de- 
hydrogenase, and GAPDH have been found to bind with high 
affinity to structural proteins of the muscle such as F-actin, 
myosin, and actomyosin (8, 44).  However, information re- 
garding the binding domains within these proteins is not 
known. In the present study, we have localized the binding 
site of myosin for SDH to be in the myosin globular domain 
(S-1 fragment of HMM) and not the or-helical portion (S-2 
fragment of HMM and LMM). Similarly, SDH did not bind 
to the ol-helical coiled-coil molecules tropomyosin, M6 pro- 
tein, or the light chain of myosin. Since cytoskeletal mole- 
cules are restricted to the cytoplasmic side of the cell mem- 
brane and are not located on the cell surface, the significance 
of the interaction of SDH with the ATPase domain of my- 
osin and to actin is not readily apparent. 
It is not surprising that SDH has both enzymatic and mul- 
tiple binding activity since several recent reports have sug- 
gested an involvement of eukaryotic membrane-bound GAPDH 
in a variety of cellular events. These include: (a) a regulatory 
role in the bunclling/unbundling  of microtubules isolated from 
brain by a mechanism involving conversion of enzyme te- 
trainers (which catalyze the bundling of microtubules) into 
dimers (which unbundle microtubules) in an ATP-dependent 
manner (13); (b) involvements in the assembly of  junctional 
triads from transverse tubules in skeletal muscle cells (9); (c) 
protein kinase activity of GAPDH to phosphorylate transverse- 
tubule protein (14); (d) single-stranded DNA-binding activity 
regulating transcription similar to that observed for nonhis- 
tone protein (15, 57);  and (e) human nuclear uracil  DNA 
glycocylase  activity (16). Thus, in the case of SDH, its GAPDH 
activity coupled with its multiple binding capacity for fibro- 
nectin, lysozyme, and cytoskeletal proteins may reflect the 
complexities involved in the infection process. 
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